Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$83.92 -1.56 (-1.82%)
At close: Oct 1, 2026 · 4:00 PM EDT

Mirum Pharmaceuticals (MIRM) Return on Equity [ROE] (2019 - 2026)

Updated

Mirum Pharmaceuticals (MIRM) recorded Return on Equity [ROE] of -741.33% in Q2 2026, down 717.35 percentage points from -23.98% a year earlier and down 454.59 percentage points from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Return on Equity [ROE] (2019 - 2026) Analysis & Trends

For FY2025, Mirum Pharmaceuticals reported Return on Equity [ROE] of -8.65%, up 28.43 percentage points from FY2024.

  • Annual Return on Equity [ROE] has increased for three straight years, with a five-year change of +59.64 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -37.08% in FY2024 (+46.57 pp), -83.65% in FY2023 (+19.81 pp), -103.46% in FY2022 (-46.00 pp) and -57.47% in FY2021 (+10.82 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q4 2019.
  • On a year-over-year basis, Return on Equity [ROE] rose in six of the last eight quarters, with an average year-over-year change of -97.58 percentage points.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 205.20 percentage points in Q3 2022, against a drop of 717.35 percentage points in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -286.74% (Q1 2026), -7.70% (Q4 2025) and -15.14% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Mirum Pharmaceuticals 5.54 Bn 3.95 Bn 145.90 Mn -741.33%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -741.33%
Mar 31, 2026 -286.74%
Dec 31, 2025 -7.70%
Sep 30, 2025 -15.14%
Jun 30, 2025 -23.98%
Mar 31, 2025 -33.71%
Dec 31, 2024 -38.43%
Sep 30, 2024 -43.30%
Jun 30, 2024 -47.09%
Mar 31, 2024 -65.62%
Dec 31, 2023 -63.12%
Sep 30, 2023 -94.44%
Jun 30, 2023 -160.45%
Mar 31, 2023 -91.24%
Dec 31, 2022 -87.15%
Sep 30, 2022 -29.78%
Jun 30, 2022 -48.35%
Mar 31, 2022 -61.15%
Dec 31, 2021 -95.11%
Sep 30, 2021 -234.97%
API Access

Mirum Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MIRM&period=max&api_key=YOUR_API_KEY